Generation and Characterization of E1/E2a/E3/E4-Deficient Adenoviral Vectors Encoding Human Factor VIII
Open Access
- 1 March 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (3), 329-336
- https://doi.org/10.1006/mthe.2001.0264
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Adenoviral Vector-Mediated Expression of Physiologic Levels of Human Factor VIII in Nonhuman PrimatesHuman Gene Therapy, 1999
- In vivo evaluation of a novel epitope‐tagged human factor VIII‐encoding adenoviral vectorHaemophilia, 1999
- Nonspecific Inflammation Inhibits Adenovirus-Mediated Pulmonary Gene Transfer and Expression Independent of Specific Acquired Immune ResponsesHuman Gene Therapy, 1998
- Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressingα1-Antitrypsin after Systemic DeliveryHuman Gene Therapy, 1998
- Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expressionGene Therapy, 1997
- Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vectorGene Therapy, 1997
- High-Level Tissue-Specific Expression of Functional Human Factor VIII in MiceHuman Gene Therapy, 1996
- In VivoGene Delivery and Expression of Physiological Levels of Functional Human Factor VIII in MiceHuman Gene Therapy, 1995
- Utilization of cellular transcription factors for adenovirus-induced transcriptionVirus Research, 1991
- Virus‐vs endotoxin‐induced activation of liver macrophagesEuropean Journal of Biochemistry, 1990